Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00522405

Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

Sponsor: All India Institute of Medical Sciences

Interventions TACE

Updated 6 times since 2017 Last updated: Jul 13, 2012 Started: Oct 31, 2007 Primary completion: Aug 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Hepatocellular Carcinoma and is currently ongoing. All India Institute of Medical Sciences leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Jul 2025 — Present [monthly]

Unknown PHASE2/PHASE3
Sep 2024 — Jul 2025 [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

All India Institute of Medical Sciences
Indian Council of Medical Research

Data source: All India Institute of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Delhi, India